Idiopathic pulmonary arterial hypertension — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Escalate therapy through a specialist pulmonary hypertension centre
Intermediate-high or high-risk PAH despite dual therapy requires specialist-centre escalation, often including prostacyclin pathway therapy or trial consideration. Inhaled airway therapy does not treat pulmonary vascular remodelling. Diuretics and oxygen can support selected patients but are not definitive escalation for worsening PAH.
Reference: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/